H.C. Wainwright Downgrades Landos Biopharma (LABP) to Neutral

April 1, 2024 6:13 AM EDT Send to a Friend
(Updated - April 1, 2024 6:44 AM EDT)

H.C. Wainwright analyst Raghuram Selvaraju downgraded Landos Biopharma (NASDAQ: LABP) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login